A prospective randomized study of CHOP versus CHOP plus alpha-2B interferon in patients with intermediate and high grade non-Hodgkin's lymphoma: The International Oncology Study Group NHL1 study

Giles, FJ; Shan, JQ; Advani, SH; Akan, H; Aydogdu, I; Aziz, Z; Azim, HA; Bapsy, PP; Buyukkececi, F; Chaimongkol, B; Chen, PM; Cheong, SK; Ferhanoglu, B; Hamza, R; Khalid, HM; Intragumtornchai, T; Kim, SW; Kim, SY; Koc, H; Kumar, L; Kumar, R; Lei, KI; Lekhakula, A; Muthalib, A; Patel, M; Poovalingam, VP; Prayoonwiwat, W; Rana, F; Reksodiputro, AH; Ruff, P; Sagar, TG; Schwarer, AP; Song, HS; Suh, CW; Suharti, C; Supindiman, I; Tee, GY; Thamprasit, T; Villalon, AH; Wickham, NR; Wong, JE; Yalcin, A; Jootar, S

doi:10.3109/10428190009054885

A prospective randomized study of CHOP versus CHOP plus alpha-2B interferon in patients with intermediate and high grade non-Hodgkin's lymphoma: The International Oncology Study Group NHL1 study

Atıf İçin Kopyala

Giles F., Shan J., Advani S., Akan H., Aydogdu I., Aziz Z., ...Daha Fazla

LEUKEMIA & LYMPHOMA, cilt.40, ss.95-103, 2000 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 40
Basım Tarihi: 2000
Doi Numarası: 10.3109/10428190009054885
Dergi Adı: LEUKEMIA & LYMPHOMA
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.95-103
İnönü Üniversitesi Adresli: Hayır

Özet

The addition of a brief alpha interferon regimen to each CHOP induction cycle, plus one year of alpha interferon thrice weekly maintenance therapy, has no early effect on response rates or survival in patients with Intermediate or High grade cell NHL.